Future of Digital Clinical Trials

November 17, 2021 11:00 AM - 11:45 AM

Virtual

Add to Calendar 11/17/2021 11:00:00 AM 11/17/2021 11:45:00 AM Future of Digital Clinical Trials

So much has been learned about the need to decentralize clinical trials during COVID, our panelists will discuss the overall landscape and considerations involved, including:

Join us for the virtual panel to hear:

  • Examples of how to conduct a decentralized trial
  • Regulatory considerations and current FDA guidelines
  • The expanded role of patients when trial are decentralized
MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning. Virtual, Link available after registration
Project Manager, Digital Medicine and Translational Imaging, Pfizer
Pirinka Georgiev is a Project Manager within Digital Medicine and Translational Imaging in Pfizer's Early Clinical Development organization. Pirinka has a diverse background in supporting clinical trials by operationalizing and implementing sensors, wearables, and other digital health technologies across various programs. Since the beginning of the COVID-19 pandemic, Pirinka has managed one of Pfizer's largest decentralized clinical trials, focusing on remote monitoring of respiratory illness. Before joining Pfizer, Pirinka studied at the University of Michigan College of Pharmacy and received her degree in Pharmaceutical Science.